Overview
Continuing Education credits are not available for archived webinars
This archive available for purchase through March 31, 2015
Broadcast time: 1 hour 44 minutes
Please note: Due to video use within the presentation, it may take up to 10 minutes to buffer and for the archive to begin playing.
Personalized medicines and companion diagnostics are making it possible to better target drugs so the right drug goes to the right person at the right time. In addition, clinical trials can be made smaller and less costly by restricting them to patients most likely to benefit from the drug. Previously, drugs were developed and tested in a whole population. Now drugs are being developed for specific people so that we don’t give the drug to somebody who’s going to have an adverse event. But how is this new world of personalized medicine regulated?
This webinar will focus on how new product development will look in the future, how it will be regulated, and how it will change the way we practice medicine.
Have an account?
Ways to register
- Individual registration is a license for ONE internet login allowing one viewer.
- Group site registration is a license for ONE internet login allowing multiple viewers from one location.
- Group Plus is a license for up to FIVE internet logins allowing one or more viewers at each login location.
Cancellations: No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.
Participants with Disabilities: Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.